Narendra Verma | Biochemistry | Research Excellence Award

Research Excellence Award

Narendra Verma
Affiliation Centre of BioMedical Research Lucknow
Country India
Scopus ID 57191708464
Documents 18
Citations 1,303
h-index 10
Subject Area Biochemistry, Genetics and Molecular Biology
Event International Academic Achievements & Awards

Narendra Verma
Centre of BioMedical Research Lucknow, India

Narendra Verma is an Indian molecular biologist and geneticist currently serving as Assistant Professor in the Department of Systems Biology at the Centre of Biomedical Research (CBMR), Lucknow. His research spans genetics, transcriptomics, metabolic biology, cancer signaling, adipose tissue physiology, and cellular regulatory mechanisms. Through collaborations with leading international laboratories, he has contributed to advances in cancer biology, obesity research, metabolic disorders, and molecular signaling pathways.[1]

Abstract

Narendra Verma has established a multidisciplinary research portfolio focused on molecular genetics, cancer biology, obesity, metabolic disorders, and transcriptomic regulation. His scholarly contributions include highly cited publications in leading journals such as Nature, Cancer Cell, Oncogene, Stem Cells, and Journal of Biological Chemistry. His current work investigates glycophagy-mediated metabolic regulation in diabetes-induced fatty liver disease through an ICMR-funded project.[2]

Keywords

Genetics, Molecular Biology, Transcriptomics, Cell Signaling, Cancer Biology, Obesity, Metabolism, Adipose Tissue, Diabetes, Glycophagy.

Introduction

Following academic training in biotechnology and molecular genetics in India and Italy, Dr. Verma developed expertise in transcriptional regulation, metabolic signaling, and disease mechanisms. His research integrates experimental biology with translational applications aimed at understanding metabolic and oncogenic processes.[3]

Research Profile

His investigations have explored Sox2-mediated tumorigenesis, YAP signaling regulation, adipocyte metabolism, thermogenesis, inflammatory signaling, and metabolic dysfunction. These studies combine cellular, molecular, and genomic approaches to address fundamental biomedical questions.[4]

Research Contributions

  • Identified Sox2-dependent mechanisms in osteosarcoma development.
  • Advanced understanding of YAP signaling in cancer progression.
  • Contributed to landmark Nature research on fungal microbiome-driven pancreatic oncogenesis.
  • Investigated thermogenic and adipocyte regulatory pathways.
  • Leading ICMR-funded studies on glycophagy and fatty liver disease.

Publications

Notable publications include articles in Nature, Cancer Cell, Oncogene, Stem Cells, Aging Cell, ATVB, and Journal of Biological Chemistry. Several publications have appeared in journals with significant impact factors and international visibility.[5]

Research Impact

According to Scopus data, Dr. Verma has accumulated over 1,300 citations across 18 indexed publications with an h-index of 10. His work has influenced research in cancer biology, metabolism, immunology, and molecular medicine, reflecting broad interdisciplinary relevance.[1]

Award Suitability

Dr. Verma demonstrates strong eligibility for research excellence recognition due to his impactful publication record, international collaborations, competitive grant funding, and sustained contributions to molecular and biomedical sciences. His ongoing ICMR-supported research further highlights his active role in advancing translational health research.

Conclusion

The academic achievements of Dr. Narendra Kumar Verma illustrate a productive career focused on understanding the molecular basis of disease. Through influential publications, collaborative science, and funded research programs, he continues to contribute to biomedical innovation and scientific advancement.

References

  1. Elsevier. (2026). Scopus Author Details: Narendra Kumar Verma, Author ID 57191708464.
    https://www.scopus.com/authid/detail.uri?authorId=57191708464
  2. ICMR Project Record. Unraveling the Glycophagy Receptors: Targeting HSF1-STBD1 Axis to Manage Metabolic Homeostasis in Diabetes-Induced Fatty Liver. https://cbmr.res.in/faculty-profile-single.php?qwr=DTM-FCT20#gsc.tab=0
  3. Verma N. et al. Journal of Biological Chemistry. 2020.
  4. Maurizi G., Verma N., et al. Oncogene. 2018.
  5. Aykut B., Pushalkar S., Verma N., et al. Nature. 2019.
    https://doi.org/10.1038/s41586-019-1608-2

Corantin Maurin | Biochemistry | Best Researcher Award

Dr. Corantin Maurin | Biochemistry | Best Researcher Award

Dr. Corantin Maurin | Biochemistry | Research Officer at Jean Monnet University | France

Dr. Corantin Maurin is a biomedical researcher specializing in ocular microbiology, tissue engineering, and infectious diseases. His academic and scientific career has been defined by interdisciplinary collaboration and a strong commitment to translational research that bridges clinical application with basic science. Through his work in ophthalmic bioengineering, Dr. Maurin has contributed to pioneering studies in corneal regeneration, virology, and host-pathogen interaction. His research has significantly advanced the scientific understanding of eye infections and tissue modeling, earning him recognition within both national and international academic communities. Driven by innovation and a passion for medical advancement, Dr. Maurin continues to be a respected contributor to high-impact projects and scholarly initiatives.

Academic Profile:

ORCID

Scopus

Education:

Dr. Corantin Maurin earned his Ph.D. in biomedical sciences from a prestigious research university renowned for its excellence in medical and health-related research. His doctoral work focused on corneal biology and the molecular dynamics of ocular infections. The rigorous academic training he received during his postgraduate studies allowed him to develop a solid foundation in cellular and tissue engineering, molecular diagnostics, and microbiological analysis. This academic background has equipped him with the necessary expertise to engage in interdisciplinary research and foster collaborations across various domains of biomedical science.

Experience:

Throughout his career, Dr. Corantin Maurin has held research roles in leading academic laboratories and clinical research institutions. His professional journey includes collaborations with ophthalmologists, microbiologists, and biomedical engineers on a wide range of research initiatives. He has actively contributed to international research consortia and multicenter studies focusing on infectious keratitis, corneal storage techniques, and regenerative therapies. Dr. Maurin has played a key role in designing experimental models for ocular diseases, and his contributions have helped bridge gaps between laboratory discoveries and clinical implementation. He is also involved in training early-career scientists and supporting the development of ethical research practices within his institutions.

Research Interest:

Dr. Corantin Maurin’s research interests lie at the intersection of ocular tissue engineering, infectious disease biology, and regenerative medicine. His ongoing work explores advanced techniques for corneal decellularization, femtosecond laser applications in ophthalmology, and the pathophysiology of viral and bacterial eye infections. He is particularly focused on the development of ex vivo models that replicate human ocular conditions for the purpose of testing novel therapeutic approaches. Additionally, Dr. Maurin is engaged in studies addressing the role of signaling pathways in corneal cell culture and the impact of systemic infections on eye health. His interdisciplinary approach allows him to address complex clinical challenges with innovative scientific solutions.

Award:

Dr. Corantin Maurin has been nominated for this award in recognition of his outstanding contributions to the fields of biomedical science and ocular research. His consistent efforts in publishing peer-reviewed work, participation in international collaborations, and commitment to advancing clinical knowledge through research have made him a prominent figure in his domain. He has received acknowledgment from institutional bodies and research peers for his ability to lead and support transformative projects that improve health outcomes and promote scientific excellence.

Selected Publications:

  • Femtosecond Laser Cutting of Human Crystalline Lens Capsule and Decellularization for Corneal Endothelial Bioengineering (Published: 2024, Citations: 5)

  • Investigating the Role of TGF-β Signaling Pathways in Human Corneal Endothelial Cell Primary Culture (Published: 2023, Citations: 18)

  • Exploration of the Ocular Surface Infection by SARS-CoV-2 and Implications for Corneal Donation: An Ex Vivo Study (Published: 2022, Citations: 42)

  • Key Role of Staphylococcal Fibronectin-Binding Proteins During the Initial Stage of Staphylococcus aureus Keratitis in Humans (Published: 2021, Citations: 29)

Conclusion:

Dr. Corantin Maurin is a dedicated biomedical scientist whose work continues to shape the landscape of ocular research and regenerative medicine. His deep engagement with innovative tissue engineering approaches, infectious disease modeling, and translational science marks him as a leader in his field. With a strong academic foundation, a growing publication record, and proven experience in collaborative research, Dr. Maurin stands out as a highly deserving candidate for this award. His future holds significant promise, not only in advancing scientific knowledge but also in mentoring emerging researchers and contributing to global health solutions through biomedical innovation.